NCT04555694View on ClinicalTrials.gov

Comparing Treatment of Dry Eye With Intracanalicular Dexamethasone, Restasis, and/or Lotemax

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

February 16, 2022

Study Completion Date

February 16, 2022

Conditions
Dry Eye
Interventions
DRUG

Cyclosporine

Used to increase tear production in patients who have dry eye caused by inflammation

DRUG

Loteprednol Etabonate

Used to treat inflammation of the eye

DRUG

Dexamethasone Ophthalmic 0.4 Mg Ophthalmic Insert

Used to treat inflammation of the eye

Trial Locations (1)

44141

Cleveland Eye Clinic, Brecksville

All Listed Sponsors
lead

Thomas Chester, OD

OTHER

NCT04555694 - Comparing Treatment of Dry Eye With Intracanalicular Dexamethasone, Restasis, and/or Lotemax | Biotech Hunter | Biotech Hunter